Experiment 350268
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | EXTERNAL |
| Organism | Empty organism |
| Citation | SANBORN,WJ: TREMAINE,WJ: OFFORD,KP: LAWSON,GM: PETERSEN,BT: BATTS,KP: CROGHAN,IT: DALE,LC: SCHROEDER,DR: HURT,RD:. (1997). TRANSDERMAL NICOTINE FOR MILDLY TO MODERATELY ACTIVE ULCERATIVE COLITIS. A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL.. 126(5) |
| Amount utilized | |
| Compound isolated | |
| Disease | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL WAS PERFORMED TO DETERMINE THE EFFECT OF TRANSDERMAL NICOTINE ON 64 NONSMOKING PATIENTS WITH ULCERATIVE COLITIS. AFTER 4 WKS 39% OF THE PATIENTS SHOWED CLINICAL IMPROVEMENT AS COMPARED TO 30% OF THE PLACEBO GROUP. |
| Dose amount | 22.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |